Adial Pharmaceuticals Plans to Enter Genetic Testing Market Following Allowance of U.S. Patent for Genetic Diagnostic Test
June 22, 2021 09:55 ET
|
Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., June 22, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on developing therapies for the...
Adial Pharmaceuticals Comments on Article in ‘The Atlantic,’ Highlighting the Second Pandemic of Addiction
June 07, 2021 09:30 ET
|
Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., June 07, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
Adial Announces Funding of Management-Led $2,100,000 Above Market Private Placement at $3.00 Per Share
June 03, 2021 09:54 ET
|
Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., June 03, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
Adial Pharmaceuticals Featured on Multiple News Broadcasts Nationwide Regarding the Second Pandemic of Alcohol Use Disorder
May 18, 2021 13:19 ET
|
Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., May 18, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial”), a clinical-stage biopharmaceutical company focused on the development of...
Adial Founder and Chief Medical Officer Dr. Bankole Johnson Featured Guest on The Black News Channel
March 17, 2021 10:00 ET
|
Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on...
Adial Announces Management-Led $2,100,000 Above Market Private Placement at $3.00 Per Share
March 15, 2021 09:30 ET
|
Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., March 15, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on...
Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion
February 26, 2021 15:05 ET
|
Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial”), a clinical-stage biopharmaceutical company focused on the development of...
Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants
February 26, 2021 11:20 ET
|
Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the...
Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial
February 25, 2021 09:30 ET
|
Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for...
Adial to File Fast Track Application for AD04 with the FDA
February 23, 2021 13:00 ET
|
Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the...